17d
Medical Device Network on MSNFDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component, Persona Revision SoluTion Femur, to provide an option for individuals ...
13d
Zacks Investment Research on MSNZimmer Biomet Focuses on Innovation Amid Growing CompetitionZimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...
WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k ...
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTionTM Femur, a revision knee implant component offering an alternative for patients with ...
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTionâ„¢ Femur, a revision knee implant component offering an alternative for patients with ...
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona ...
Zimmer Biomet Holdings, Inc. (ZBH), Friday announced that the company has received the U.S. Food and Drug Administration 510(k) clearance of Persona Revision SoluTion Femur, a revision knee ...
A Revision Knee ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results